AusBiotech

The award-winning Industry Mentoring Network in STEM (IMNIS) MedTech-Pharma Program has now been launched across Australia, after the program was funded on the back of a successful pilot.

Nominations are now open for the AusBiotech Board as it seeks to elect one new director.

AusBiotech will work on the 2017 Graeme Clark Oration with the Convergence Science Network and the University of Melbourne.

Australian medical device and biotech companies developing prosthetic technologies and products are called upon to share their progress after the Federal Department of Health requested a quarterly briefing document, through the PLAC.

OneVentures and leading US venture capitalist Jim Scopa are gearing up for an Australian roadshow to look for investment opportunities – and local companies are invited to express interest in...

MTPConnect will lead a delegation to attend The MedTech Conference to showcase Australia’s outstanding innovative medtech companies and build invaluable inroads into international markets.

BTC Health provides development capital and management expertise to high-growth Australian biotech, medtech and pharmaceutical companies on behalf of a strong shareholder base from its Melbourne head office.

A number of AusBiotech committees are seeking new members and AusBiotech is calling for expressions of interest to join selected committees.

Amid a range of changes to visa provisions, the Federal Government has commenced a review of Australia’s business, investment and talent visas, including Significant and Premium Investor Visa.

The Victorian Clinical Trials Gateway (VCT Gateway) – a new web-based portal - has been launched to globally connect the clinical trials ecosystem with and in Victoria.

Innovative South Australian companies are set to receive an additional $50 million in external venture capital with the announcement of the state government’s 15 year South Australian Venture Capital Fund (SAVCF) – to be managed by Blue Sky Venture Capital.